Virtual care is a double-edged sword: Adjusting preventive care service delivery in community health clinics during COVID-19

被引:0
|
作者
Papajorgji-Taylor, Dea [1 ]
Sheppler, Christina R. [1 ]
McMullen, Carmit [1 ]
O'Connor, Patrick J. [2 ]
Gold, Rachel [1 ]
机构
[1] Kaiser Permanente Northwest, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA
[2] HealthPartners Inst, Bloomington, MN USA
基金
美国国家卫生研究院;
关键词
Community health centers; COVID-19; heart disease risk factors; preventive medicine; qualitative research; telemedicine;
D O I
10.4103/jfmpc.jfmpc_1971_23
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Qualitatively examine how community health clinics delivered cardiovascular disease (CVD) preventive care during COVID-19 using virtual care and related adaptations. Methods: Semi-structured interviews were conducted in 2021-2022 with nine clinician leaders from four clinics across the country that share an electronic health record. Interviews covered: (1) the pandemic's impact on preventive care delivery, (2) the adaptation and role of virtual care, and (3) management of CVD risk in this context. Collected data were analyzed using a thematic analysis approach. Results: Staff reported substantial pros and cons to virtual care for CVD risk management. It was seen as useful for general check-ins with patients. However, without current laboratory results and vital measurements, providers found it challenging to assess patient CVD risk and direct care accordingly. Conclusion: Findings add to the evolving evidence base that the necessary pivot to virtual care during the pandemic spurred innovations but also created limitations and delays in delivering appropriate preventive care.
引用
收藏
页码:3792 / 3797
页数:6
相关论文
共 50 条
  • [1] Tocilizumab in COVID-19: A Double-Edged Sword?
    Kudlinski, Bartosz
    Zawadzki, Jacek
    Kulinska, Wiktoria
    Kania, Jagoda
    Murkos, Magdalena
    Stolinska, Marta
    Zgola, Dominika
    Noga, Anna
    Nowak, Pawel
    BIOMEDICINES, 2024, 12 (12)
  • [2] Active smoking and COVID-19: a double-edged sword
    Lippi, Giuseppe
    Sanchis-Gomar, Fabian
    Henry, Brandon Michael
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 77 : 123 - 124
  • [3] Regulated necrosis in COVID-19: A double-edged sword
    Sun, Chen
    Han, Yunze
    Zhang, Ruoyu
    Liu, Simon
    Wang, Jing
    Zhang, Yuqing
    Chen, Xuemei
    Jiang, Chao
    Wang, Junmin
    Fan, Xiaochong
    Wang, Jian
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Double-edged sword effect of platelets in COVID-19
    Jadali, Zohreh
    JORNAL VASCULAR BRASILEIRO, 2023, 22
  • [5] Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
    Ritchie, Andrew I.
    Singanayagam, Aran
    LANCET, 2020, 395 (10230): : 1111 - 1111
  • [6] Double-edged sword effect of anticoagulant in COVID-19 infection
    Ohn, May Honey
    Ng, Jun Rong
    Ohn, Khin Maung
    Luen, Ng Pey
    BMJ CASE REPORTS, 2021, 14 (03)
  • [7] Trust: A Double-Edged Sword in Combating the COVID-19 Pandemic?
    Reiersen, Jon
    Roll, Kristin
    Williams, Jesse Dylan
    Carlsson, Michael
    FRONTIERS IN COMMUNICATION, 2022, 7
  • [8] mTOR inhibition: a double-edged sword in patients with COVID-19?
    Morteza Ghasemnejad-Berenji
    Human Cell, 2021, 34 : 698 - 699
  • [9] Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers
    Yang, Ruixin
    Yu, Yingyan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1530 - 1537
  • [10] Fluid Therapy: Double-Edged Sword during Critical Care?
    Benes, Jan
    Kirov, Mikhail
    Kuzkov, Vsevolod
    Lainscak, Mitja
    Molnar, Zsolt
    Voga, Gorazd
    Monnet, Xavier
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015